Join the India Equity Telegram Group for analysis, updates and results

NATHBIOGEN has declared results for the period ended Jun 2021.

Quarterly Results

[s2If !current_user_can(access_s2member_level1)] Register and Login below to read result analysis [lwa][/s2If] [s2If current_user_can(access_s2member_level1)]

• Sales for period ended Jun 2021 is Rs 215.0 cr compared to Rs 194.0 cr for period ended Jun 2020, a rise of 10.8%
• Operating Profits reported at Rs 49.0 cr for period ended Jun 2021 vis-vis 44.0 for period ended Jun 2020 .
• Operating Margins expanded 11.0 bps for period ended Jun 2021 vis-vis Jun 2020 .
• The EPS for Jun 2021 was Rs 23.63 compared to Rs 3.76 for previous quarter ended Mar 2021 and Rs 21.71 for Jun 2020
• The stock is trading at Rs 362 and a market cap of Rs 688 cr

[/s2If]

Trading Chart

Further analysis and Full Company Research with investing scores is available here: NATHBIOGEN

Join BharatEquity Telegram Channel for updated India results, analysis and News
Join Our Twitter